The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed using repeated 24 hour dietary records and evaluated t ...

The latest consensus earnings revisions foretell a robust Rule of 40 score for Meta Platforms ahead. Click here to read my ...

Traditional security measures like firewalls and antivirus software are no longer sufficient to protect organizations from ...

The company’s new Keysight AI Software Integrity Builder is designed to help engineering teams assess, explain and monitor AI behaviour throughout its lifecycle, as regulatory oversight increases and ...

Radio telescopes have long scanned quiet patches of sky for a lone, artificial-sounding ping, but a growing body of research ...

The Bureau of Labor Statistics (BLS) confirmed to Benzinga on Wednesday that it is grappling with a staffing crisis, ...

Scientists uncover key reason behind frequent overlap of mental disordersWhat if the boundaries between mental health ...

Introduction Cancer care in humanitarian settings is very challenging, and patients may face significant barriers to ...

Educational systems in Sub-Saharan Africa face significant challenges in aligning curricula and pedagogical approaches with ...

A cautionary tale from the battery industry, where misplaced confidence in conventional sales tactics nearly cost a company ...

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...